tirzepatide serotonin syndrome Journal Of Paramedic Practice - toxicity: pre-hospital recognition and management Serotonin syndrome: a brief review

Finally, people with a history of alcohol use disorder deserve special mention

The STEP 1 extension study found participants regained about two-thirds of the weight they'd lost within a year after discontinuing

"Tirzepatide effectively reduced drive to eat, as well as food-cue-driven and other-cue-driven eating behavior." Nature Medicine This effect is due to tirzepatides action on both GIP and GLP-1 receptors, which slows gastric emptying, signals fullness to the brain, and improves insulin sensitivity

[DOI] [PubMed] [Google Scholar] 3.Foster NC, Beck RW, Miller KM, et al

But it is almost certainly caused by the downstream effects of the medication rather than the drug itself, and that distinction matters enormously when it comes to treatment